Coeptis Therapeutics, Inc. (COEP)

NASDAQ: COEP · IEX Real-Time Price · USD
1.58
+0.08 (5.33%)
Jan 27, 2023, 4:00 PM EST - Market closed

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year 202120202019
Revenue
0.080.030
Revenue Growth (YoY)
143.82%--
Cost of Revenue
00.960
Gross Profit
0.08-0.930
Selling, General & Admin
14.125.780
Research & Development
000
Operating Expenses
14.125.780
Operating Income
-14.05-6.71-0
Interest Expense / Income
0.190.150
Other Expense / Income
-0.782.29-
Pretax Income
-13.45-9.16-0
Net Income
-13.45-9.16-0
Shares Outstanding (Basic)
32182
Shares Outstanding (Diluted)
32182
Shares Change
79.11%944.93%-
EPS (Basic)
-0.42-0.51-
EPS (Diluted)
-0.42-0.51-
Free Cash Flow Per Share
-0.14-0.17-0.00
Gross Margin
100.00%-3034.54%-
Operating Margin
-18727.91%-21823.77%-
Profit Margin
-17932.37%-29765.89%-
Free Cash Flow Margin
-5985.92%-10195.12%-
EBITDA
-12.81-8.68-0
EBITDA Margin
-17086.31%-28232.72%-
Depreciation & Amortization
0.450.320
EBIT
-13.26-9.01-0
EBIT Margin
-17682.86%-29284.14%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).